| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Nov―10 |
Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor |
Jose Jimeno, Jose Felipe Varona, Jose A. Lopez-Martin, Nuria Izquierdo-Useros, Elisa Molina Molina, Pablo Guisado-Vasco, et al. (+16) Martin Sachse, Cristina Risco, Alejandro Losada, Salvador Fudio, Erik Luepke, Antonio Nieto, Javier Gomez, Pablo Aviles, Carmen Cuevas, Mehdi Bouhaddou, Isabel Sola, Nevan J. Krogan, Luis Enjuanes, Jose M. Fernandez-Sousa, Adolfo GarcÍa-Sastre, Kris White |
| 2 |
[GO] |
2025―Sep―27 |
The double-edged sword: How SARS-CoV-2 might fuel lung cancer: Investigating the potential oncogenic mechanisms of the novel coronavirus in lung carcinogenesis |
Wang Shen, Yaohua Guo, Cheng Ai, Xuehai Wang, Gang Li |
| 3 |
[GO] |
2025―Sep―12 |
Urogenital manifestations of SARS-CoV-2, MPXV and Zika virus: A comprehensive review |
Yubin Li, Guanghan Fan, Huadong He |
| 4 |
[GO] |
2022―Okt―28 |
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics |
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, Amoghavarsha Venugopal, Vasili Pleqi, Caleb A. Weber, et al. (+5) Rohit Chitale, Ravi Durvasula, Christopher Hopkins, Prakasha Kempaiah, Thomas R. Caulfield |
| 5 |
[GO] |
2021―Aug―13 |
Innate lymphoid cells (ILC) in SARS-CoV-2 infection |
Amrita Kumar, Weiping Cao, Kedan Endrias, Suresh V. Kuchipudi, Suresh K. Mittal, Suryaprakash Sambhara |
| 6 |
[GO] |
2021―Jan―28 |
The Need for Precision Nutrition, Genetic Variation and Resolution in Covid-19 Patients |
Artemis P. Simopoulos, Charles N. Serhan, Richard P. Bazinet |
|
